ECSP003761A - SILKED HETEROCICLIC COMPOUNDS - Google Patents

SILKED HETEROCICLIC COMPOUNDS

Info

Publication number
ECSP003761A
ECSP003761A EC2000003761A ECSP003761A ECSP003761A EC SP003761 A ECSP003761 A EC SP003761A EC 2000003761 A EC2000003761 A EC 2000003761A EC SP003761 A ECSP003761 A EC SP003761A EC SP003761 A ECSP003761 A EC SP003761A
Authority
EC
Ecuador
Prior art keywords
silked
compounds
heterociclic compounds
heterociclic
formula
Prior art date
Application number
EC2000003761A
Other languages
Spanish (es)
Inventor
Joachim Nozulak
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ECSP003761A publication Critical patent/ECSP003761A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención proporciona un compuesto de fórmula I: en donde X y R1 a R5 son como se definen en la descripción, y la preparación del mismo. Los compuestos de la fórmula I son útiles como productos farmacéuticos.The invention provides a compound of formula I: wherein X and R1 to R5 are as defined in the description, and the preparation thereof. The compounds of the formula I are useful as pharmaceuticals.

EC2000003761A 1999-11-15 2000-11-10 SILKED HETEROCICLIC COMPOUNDS ECSP003761A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19954847 1999-11-15

Publications (1)

Publication Number Publication Date
ECSP003761A true ECSP003761A (en) 2002-06-26

Family

ID=7929072

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2000003761A ECSP003761A (en) 1999-11-15 2000-11-10 SILKED HETEROCICLIC COMPOUNDS

Country Status (6)

Country Link
AR (1) AR026451A1 (en)
AU (1) AU2356301A (en)
CO (1) CO5261532A1 (en)
EC (1) ECSP003761A (en)
PE (1) PE20011023A1 (en)
WO (1) WO2001036428A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10729710B2 (en) 2017-11-24 2020-08-04 H. Lundbeck A/S Catecholamine prodrugs for use in the treatment of Parkinson's disease
US11111263B2 (en) 2019-05-20 2021-09-07 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11130775B2 (en) 2019-05-20 2021-09-28 H. Lundbeck A/S Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11104697B2 (en) 2019-05-20 2021-08-31 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11168056B2 (en) 2019-05-20 2021-11-09 H. Lundbeck A/S Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol
CN113677675B (en) 2019-05-21 2024-07-26 H.隆德贝克有限公司 Novel catecholamine prodrugs for the treatment of parkinson's disease
JP7641234B2 (en) 2019-05-21 2025-03-06 ハー・ルンドベック・アクチエゼルスカベット Novel catecholamine prodrugs for use in the treatment of Parkinson's disease
EP3972600A1 (en) 2019-05-21 2022-03-30 H. Lundbeck A/S Catecholamine carbamate prodrugs for use in the treatment of parkinson s disease
WO2020234276A1 (en) 2019-05-21 2020-11-26 H. Lundbeck A/S New catecholamine prodrugs for use in the treatment of parkinson's disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2689892A1 (en) * 1992-04-09 1993-10-15 Rhone Poulenc Rorer Sa New 4-substd. 1,4-di:phenyl-1-sila:cyclopentane derivs. - used as serotonin antagonists e.g. for treating anxiety, migraine, asthma or hypertension
US6210705B1 (en) * 1997-12-15 2001-04-03 Noven Pharmaceuticals, Nc. Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate

Also Published As

Publication number Publication date
CO5261532A1 (en) 2003-03-31
PE20011023A1 (en) 2001-09-27
AR026451A1 (en) 2003-02-12
WO2001036428A1 (en) 2001-05-25
AU2356301A (en) 2001-05-30

Similar Documents

Publication Publication Date Title
PA8527001A1 (en) USEFUL POLYARILCARBOXAMIDS AS LIPID REDUCING AGENTS
UY27381A1 (en) 2-TIO-3,5-DICIANO-4-FENIL-6-REPLACED AMINOPIRIDINS AND THEIR USE
UY27571A1 (en) 2-TIO-3, 5-DICIAN-4-PHENYL-6-REPLACED AMINOPIRIDINS AND THEIR USE
CR6935A (en) B3-ADRENERGIC RECEIVER AGENTS AND USES OF THE SAME
BR0115436A (en) Piperazinylpyrazine Compounds Acting as Serotonin 5ht-2 Receptor Antagonists
ATE403429T1 (en) SPIROPYRAZOLE COMPOUNDS
ATE270817T1 (en) FUNGICIDES
CR9113A (en) ACETAMIDE COMPOUNDS AS FUNGICIDES
ES2183331T3 (en) SULFAMIDA-METALOPROTEASA INHIBITORS.
CY1108567T1 (en) ANTI-THROUGH UNITS
ES2159488B1 (en) PROCEDURE FOR THE PREPARATION OF PIRIMIDONE DERIVATIVES WITH ANTIFUNGIC ACTIVITY.
ECSP055863A (en) PYRIDODIACINS AS FUNGUICIDES OF PLANTS
SE9901077D0 (en) Novel use
ECSP034754A (en) DERIVATIVES OF BETA-CARBOLINA AND ITS PHARMACEUTICAL USE AGAINST DEPRESSION AND ANXIETY
ECSP003761A (en) SILKED HETEROCICLIC COMPOUNDS
BR0115996A (en) Sulfamidothienopyrimidines
ECSP024377A (en) DERIVATIVES OF BENZO (G) QUINOLINA
TR200402546T4 (en) Process for preparing taxane derivatives.
CO5080802A1 (en) NEW INHIBITING HETEROCICLICAL COMPOUNDS OF PHOSPHODESTERESA IV AND ITS FORMULATION AND USE AS PHARMACEUTICAL PRODUCTS
DK1206452T3 (en) Process for the preparation of benzoperhydroisoindole compounds
MX9708510A (en) TETRALINS.
DE60043228D1 (en) PREPARATION OF 2-CYANOPYRIDINES
ES2157419T3 (en) ARILAZADIOXACICLOALQUENOS SUBSTITUIDOS, FUNGICIDAS.
ID27733A (en) METHODIMINOFENILASETAMIDA
AR023979A1 (en) PROCESSES TO PREPARE INTERMEDIATE PESTICIDE COMPOUNDS